These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 38247540)

  • 1. Anastrozole Protects against Human Coronavirus Infection by Ameliorating the Reactive Oxygen Species-Mediated Inflammatory Response.
    Kwon EB; Kim B; Kim YS; Choi JG
    Antioxidants (Basel); 2024 Jan; 13(1):. PubMed ID: 38247540
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Broad antiviral and anti-inflammatory activity of Qingwenjiere mixture against SARS-CoV-2 and other human coronavirus infections.
    Xie P; Fang Y; Shen Z; Shao Y; Ma Q; Yang Z; Zhao J; Li H; Li R; Dong S; Wen W; Xia X
    Phytomedicine; 2021 Dec; 93():153808. PubMed ID: 34753027
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of Jinzhen granule on two coronaviruses: The novel SARS-CoV-2 and the HCoV-229E and the evidences for their mechanisms of action.
    Ma Q; Wang Z; Chen R; Lei B; Liu B; Jiang H; Chen Z; Cai X; Guo X; Zhou M; Huang J; Li X; Dai J; Yang Z
    Phytomedicine; 2022 Jan; 95():153874. PubMed ID: 34923232
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human Coronavirus 229E Infection Inactivates Pyroptosis Executioner Gasdermin D but Ultimately Leads to Lytic Cell Death Partly Mediated by Gasdermin E.
    Martiáñez-Vendrell X; Bloeme-Ter Horst J; Hutchinson R; Guy C; Bowie AG; Kikkert M
    Viruses; 2024 Jun; 16(6):. PubMed ID: 38932190
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytopathic Effect Assay and Plaque Assay to Evaluate
    Hu Y; Ma C; Wang J
    Bio Protoc; 2022 Feb; 12(3):e4314. PubMed ID: 35284599
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Severe Acute Respiratory Syndrome Coronavirus 2 Vaccination Boosts Neutralizing Activity Against Seasonal Human Coronaviruses.
    Lawrenz J; Xie Q; Zech F; Weil T; Seidel A; Krnavek D; van der Hoek L; Münch J; Müller JA; Kirchhoff F
    Clin Infect Dis; 2022 Aug; 75(1):e653-e661. PubMed ID: 35079775
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The dominance of human coronavirus OC43 and NL63 infections in infants.
    Dijkman R; Jebbink MF; Gaunt E; Rossen JW; Templeton KE; Kuijpers TW; van der Hoek L
    J Clin Virol; 2012 Feb; 53(2):135-9. PubMed ID: 22188723
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human Milk Antibodies Against S1 and S2 Subunits from SARS-CoV-2, HCoV-OC43, and HCoV-229E in Mothers with A Confirmed COVID-19 PCR, Viral SYMPTOMS, and Unexposed Mothers.
    Demers-Mathieu V; DaPra C; Mathijssen G; A Sela D; M Jarvinen K; Seppo A; Fels S; Medo E
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33572480
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transcriptomic profiling and genomic mutational analysis of Human coronavirus (HCoV)-229E -infected human cells.
    Friedman N; Jacob-Hirsch J; Drori Y; Eran E; Kol N; Nayshool O; Mendelson E; Rechavi G; Mandelboim M
    PLoS One; 2021; 16(2):e0247128. PubMed ID: 33630927
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pulsed blue light inactivates two strains of human coronavirus.
    Enwemeka CS; Bumah VV; Mokili JL
    J Photochem Photobiol B; 2021 Sep; 222():112282. PubMed ID: 34404018
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An overview on the seven pathogenic human coronaviruses.
    Kesheh MM; Hosseini P; Soltani S; Zandi M
    Rev Med Virol; 2022 Mar; 32(2):e2282. PubMed ID: 34339073
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Are higher antibody levels against seasonal human coronaviruses associated with a more robust humoral immune response after SARS-CoV-2 vaccination?
    Asamoah-Boaheng M; Grunau B; Karim ME; Jassem AN; Bolster J; Marquez AC; Scheuermeyer FX; Goldfarb DM
    Front Immunol; 2022; 13():954093. PubMed ID: 36159791
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the clinical characteristics and mortality of adults infected with human coronaviruses 229E and OC43.
    Choi WI; Kim IB; Park SJ; Ha EH; Lee CW
    Sci Rep; 2021 Feb; 11(1):4499. PubMed ID: 33627764
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic variability of human coronavirus OC43-, 229E-, and NL63-like strains and their association with lower respiratory tract infections of hospitalized infants and immunocompromised patients.
    Gerna G; Campanini G; Rovida F; Percivalle E; Sarasini A; Marchi A; Baldanti F
    J Med Virol; 2006 Jul; 78(7):938-49. PubMed ID: 16721849
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pan-Coronavirus CRISPR-CasRx Effector System Significantly Reduces Viable Titer in HCoV-OC43, HCoV-229E, and SARS-CoV-2.
    Mayes CM; Santarpia JL
    CRISPR J; 2023 Aug; 6(4):359-368. PubMed ID: 36912815
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A bivalent protein targeting glycans and HR1 domain in spike protein potently inhibited infection of SARS-CoV-2 and other human coronaviruses.
    Cai Y; Xu W; Tang J; Cao N; Lan Q; Lu L; Jiang S
    Cell Biosci; 2021 Jul; 11(1):128. PubMed ID: 34238357
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kurarinone Inhibits HCoV-OC43 Infection by Impairing the Virus-Induced Autophagic Flux in MRC-5 Human Lung Cells.
    Min JS; Kim DE; Jin YH; Kwon S
    J Clin Med; 2020 Jul; 9(7):. PubMed ID: 32674356
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Previous viral symptoms and individual mothers influenced the leveled duration of human milk antibodies cross-reactive to S1 and S2 subunits from SARS-CoV-2, HCoV-229E, and HCoV-OC43.
    Demers-Mathieu V; DaPra C; Mathijssen GB; Medo E
    J Perinatol; 2021 May; 41(5):952-960. PubMed ID: 33649442
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effective inhibition of HCoV-OC43 and SARS-CoV-2 by phytochemicals in vitro and in vivo.
    Ojha D; Jessop F; Bosio CM; Peterson KE
    Int J Antimicrob Agents; 2023 Sep; 62(3):106893. PubMed ID: 37339711
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improving human coronavirus OC43 (HCoV-OC43) research comparability in studies using HCoV-OC43 as a surrogate for SARS-CoV-2.
    Schirtzinger EE; Kim Y; Davis AS
    J Virol Methods; 2022 Jan; 299():114317. PubMed ID: 34634321
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.